The IHC and FISH scoring criteria are different for breast and gastric cancer [26, 27], reflecting intrinsic biological differences, including higher heterogeneity of HER2 membranous immunoreactivity in gastric cancer. This evidence concerns the gene ERBB2 and gastric cancer.